
AXIS Clinicals US Expands Capabilities to Conduct hADME Studies for NDA Filings
DILWORTH, Minn., Dec. 20, 2024—AXIS Clinicals US is pleased to announce the award of a Radioactive Materials License (RAM License)
Welcome to the Axis Insights Hub — a central resource for the latest developments, event updates, and expert perspectives on advances in clinical research and analytical methodologies.
Stay up to date with the latest news and events here at Axis and beyond. We will inform you about the current industry news and major activities at Axis, keeping you connected and in the know.

DILWORTH, Minn., Dec. 20, 2024—AXIS Clinicals US is pleased to announce the award of a Radioactive Materials License (RAM License)

AXIS Clinicals LLC and Joanneum Research Forschungsgesellschaft mbH are excited to announce the first ever partnership for the clinical applications

DILWORTH, MN, 1st March, 2021 – AXIS Clinicals added another member as part of the consultation team with the welcoming of Dr.
Our experts share cutting-edge insights, industry trends, and analyses spanning the full spectrum of clinical research, especially focusing on early phase trials.
Browse our comprehensive library of case studies and white papers to learn how we are advancing innovations in drug development

How AXIS Clinicals helped a global CRO recover a stalled biosimilar study during the height of COVID-19 When the pandemic disrupted clinical research worldwide, one

Drug IV Biosimilar Study Design PD and Immunogenicity assessments Multiple sites in EU and US In-house for few days followed by daily/weekly follow up visits

Drug Oral small-molecule prenylation inhibitor treatment of HepD Multiple studies Healthy volunteers equally split by gender Post menopausal women Subject Recruitment Timely recruitment/enrollment for all